Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Compass Therapeutics Inc

CMPX
1,11
0,01 (0,91%)
25 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202414:32EDGAR2Form 8-K - Current report
30/5/202414:00GLOBECompass Therapeutics to Participate in the Jefferies Global..
28/5/202422:10GLOBECompass Therapeutics Announces CEO Transition
28/5/202422:09EDGAR2Form 8-K - Current report
23/5/202423:05GLOBECompass Therapeutics to Present Phase 1 Data for CTX-471, A..
14/5/202414:00GLOBECompass Therapeutics to Participate in the H.C. Wainwright..
13/5/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202414:00EDGAR2Form 8-K - Current report
13/5/202414:00GLOBECompass Therapeutics Reports 2024 First Quarter Financial..
25/4/202414:00GLOBECompass Therapeutics Receives FDA Fast Track Designation for..
16/4/202414:00GLOBECompass Therapeutics Announces First Patient Dosed in the..
12/4/202414:00GLOBECompass Therapeutics Announces Poster Presentations at the..
10/4/202414:00GLOBECompass Therapeutics to Participate in the Stifel Targeted..
09/4/202418:00GLOBECompass Therapeutics Presents Data Demonstrating Elimination..
21/3/202414:00GLOBECompass Therapeutics Reports 2023 Financial Results and..
11/3/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:00GLOBECompass Therapeutics to Participate in the Leerink Partners..
28/2/202414:00GLOBECompass Therapeutics Announces Publication of CTX-8371..
14/2/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:30EDGAR2Form 8-K - Current report
05/1/202414:00EDGAR2Form 8-K - Current report
05/1/202414:00GLOBECompass Therapeutics Provides Corporate Update
21/11/202320:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:30EDGAR2Form 8-K - Current report
09/11/202313:30GLOBECompass Therapeutics Reports Third Quarter 2023 Financial..
07/11/202314:00GLOBECompass Therapeutics to Participate in Upcoming Investor..
30/8/202314:00GLOBECompass Therapeutics to Participate in Upcoming Investor..
03/8/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202314:00EDGAR2Form 8-K - Current report
03/8/202314:00GLOBECompass Therapeutics Reports Second Quarter 2023 Financial..
Apertura: 1,14 Min: 1,10 Max: 1,16
Chiusura: 1,10

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network